Core One Labs Inc. (CSE: COOL | OTCQB:CLABF | Frankfurt:LD6 | WKN:A3CSSU), further to its press release dated March 4, 2022, is excited to announce its wholly owned subsidiary, Akome Biotech Ltd., the Company’s bio-pharma research and development division focused on new psychedelic-based drug discovery and development targeting neurological and mental health disorders, has achieved…